Despite the large number of samples taken from patients during the course of the pandemic, researchers investigating Covid-19 continue to face a variety of obstacles that prevent them from gaining access to this essential medical evidence.
Organizations: | Genome Canada, Global Alliance for Genomics and Health, McGill, SISCAPA Assay Technologies, and Vancouver Island Antibodies |
People: | Kimberlyn McGrail, Rob Annan, Roxana Sultan, Terry Pearson, and Yann Joly |
Topics: | COVID-19, genomics, and health research |